1. Introduction {#sec1}
===============

At present, timely primary percutaneous coronary intervention (P-PCI) is the best therapeutic strategy for ST-segment-elevation myocardial infarction (STEMI) \[[@B1], [@B2]\]. Compared with patients scheduled for selective PCI, STEMI patients in P-PCI are at high risk of acute cardiac events. Many critical situations such as tachyarrhythmia, hypoperfusion, and cardiac shock could have certain adverse effects on imaging and judgment for lesions, hence then raise a claim for a good image quality.

Recent reports about radiation risk gradually raised the safety concerns for the ionizing radiation-mediated interventional therapy \[[@B3]--[@B5]\]. Although there have been some radiation reduction measures \[[@B6]--[@B9]\] reported to reduce radiation dose, all attempts were made for routine coronary angiography or selective PCI. However, as a common sense, radiation exposure reduction would inevitably affect the image quality. Up to now, the evaluation of optimized radiation strategy in P-PCI has never been reported yet.

Recently, we reported the utilization of optimized radiation strategy in chronic total occlusion- (CTO-) PCI \[[@B10]\]. Herein, by evaluating radiation dose parameters and 30-day clinical outcomes in the present study, we investigated for the first time the efficacy and safety of an optimized radiation strategy in P-PCI for STEMI patients.

2. Materials and Methods {#sec2}
========================

2.1. Study Population {#sec2.1}
---------------------

Between September 2016 and September 2017, all P-PCI for STEMI patients with an onset-to-door time of \<24 h were retrospectively screened from database of our intervention center. Unfortunately, due to setting of software, 3 X-ray systems without optimized radiation strategy could not upload the radiation dose value automatically. Therefore, all P-PCI performed within these 3 X-ray systems (*N* = 24) were excluded from the present study. As a result, a total of 214 STEMI patients were included in the present study ([Figure 1](#fig1){ref-type="fig"}). All patients were divided into optimized radiation strategy (ORS) group (*N* = 151) and normal radiation strategy (NRS) group (*N* = 63) according to the radiation protocol utilized. During the period of this study, as operators became aware of inter-equipment differences, more P-PCI was carried out following the optimized radiation strategy unless the relevant X-ray systems were occupied or in maintenance. Each P-PCI was performed according to the current guidelines \[[@B2]\] and successful PCI was defined as TIMI grade 2 to 3 flow after P-PCI.

This retrospective study was approved by the medical ethics committee of Zhongshan Hospital (No. B2017-173). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the Helsinki declaration and its later amendments.

2.2. Imaging Protocol {#sec2.2}
---------------------

The optimized radiation strategy was carried out in two identical X-ray systems (Philips AlluraXper, 2013 manufactured/2014 installed, Royal Philips Electronics, Amsterdam, Netherlands) in our intervention center, of which the radiation parameters set were consistent and synchronized. As we previously reported, the fluoroscopy frame rate was set as 15 f/s and cine-angiography frame rates as 7.5 f/s. On the other hand, a 0.9 mm/1.0 mm copper (Cu)/aluminum (Al) filter was implemented for fluoroscopy while the filter for cine-angiography was 0.1 mm/1.0 mm Cu/Al \[[@B10]\]. Correspondingly, NRS group consists of procedures performed within 2 different Siemens X-ray system (Siemens Axiom Artis Zee Biplane MN, 2009 manufactured/2010 installed, and Siemens Axiom Artis Zeego, 2011 manufactured/2011 installed, Siemens Medical Systems, Erlangen, Germany) and 1 GE system (GE Innova IGS 520, 2015 manufactured/2016 installed, GE Healthcare; Little Chalfont, United Kingdom). Both the Siemens and GE X-ray systems have set fluoroscopy frame rates as 7.5 f/s and cine-angiography frame rates as 15 f/s. The Cu filter range from 0.1--0.3 mm for fluoroscopy while not implemented for cine-angiography in both Siemens systems. A maximum of 0.3 mm Cu filter was implemented for fluoroscopy and cine-angiography in GE system. All systems mentioned above received regular radiation dose report detection and correction.

2.3. Study Endpoints {#sec2.3}
--------------------

The primary end point was the relative dose reduction of total air kerma. The value of air kerma, dose-area product (DAP), and fluoroscopy time were registered as indicated by the X-ray system. An efficiency index (EI) \[[@B11]\] was calculated by fluoroscopy time/total air kerma. The secondary endpoint was the incidence of 30-day major adverse cardiac and cerebrovascular events (MACCE), as defined by the composite of all-cause death, reinfarction, ischemia-driven target vessel revascularization, and stroke. Reinfarction was defined as the same as the reported article by Mehran et al. \[[@B12]\].

2.4. Statistical Analysis {#sec2.4}
-------------------------

The data were expressed as the mean ± SD for the continuous variables, and as frequencies for the categorical variables. The comparison of continuous variables was performed by the independent Student\'s *t*-test or the Mann-Whitney *U* test as appropriate. Statistical analysis of the categorical variables was performed using the Pearson chi-square or Fisher\'s exact test as appropriate. We used Cox proportional hazard models to estimate the impact of optimized radiation strategy to clinical outcomes adjusting for the differences in patient baseline and angiographic factors. *p* values were two-tailed, and *p* \< 0.05 was considered statistically significant. The data were analyzed with SPSS v.20.0 statistical software (SPSS, version 20.0, Inc., Chicago, IL, USA).

3. Results {#sec3}
==========

3.1. Baseline Characteristics {#sec3.1}
-----------------------------

The baseline clinical characteristics of the patients are summarized in [Table 1](#tab1){ref-type="table"}. It is apparent from this table that no significant differences were found between the 2 groups. The mean age of our cohort was 64.7 ± 11.9 years and body mass index was 24.0 ± 2.8 kg/m^2^. Anterior STEMI comprised 49.1% of the overall patients and 1.9% of all patients presented as cardiogenic shock. The 2 groups had a similar hemodynamic status, depicted by blood pressure, heart rate, and Killip class.

3.2. Angiographic and Procedural Characteristics {#sec3.2}
------------------------------------------------

Details of angiographic and procedural characteristics are depicted in [Table 2](#tab2){ref-type="table"}. A high rate of radial access was observed in both ORS group (97.4%) and NRS (93.7%) group (*p*=0.238). Multiple-vessel disease accounted for 70.6% of all patients, and non-culprit vessel PCI were implemented in 10 (4.7%) patients. There were also no significant differences for angiographic and procedural characteristics between 2 groups.

3.3. Outcomes {#sec3.3}
-------------

The differences of relevant radiation parameters between 2 groups are highlighted in [Table 2](#tab2){ref-type="table"}. Fluoroscopy time was similar between 2 groups (20.1 ± 12.8 min versus 21.7 ± 17.4 min, *p*=0.439). The radiation dose reduction in ORS group was 40.9% for air kerma (901.2 ± 628.7 mGy versus 1524.0 ± 866.6 mGy, *p* \< 0.001) and 43.5% for DAP (57.1 ± 40.7 Gycm^2^ versus 101.1 ± 59.4 Gycm^2^, *p* \< 0.001). Meanwhile, EI increased by 55.0% (24.8 ± 9.5 min/Gy versus 16.0 ± 10.2 min/Gy, *p* \< 0.001) in ORS group. Radiation dose comparison among X-ray systems within groups showed the total air kerma was comparable within NRS group, also for ORS group ([Figure 2](#fig2){ref-type="fig"}).

During 30-day period, no patient was lost to follow-up. Detailed clinical outcomes are described in [Table 3](#tab3){ref-type="table"}. The cumulative incidence of all-cause death (2.0% versus 1.6%) and stroke (0.7% versus 0%) was similar between 2 groups. No reinfarction and ischemia-driven target vessel revascularization was observed. Two death were secondary to major bleeding while the other two secondary to cardiac shock. One stroke of intracranial bleeding was observed. After adjusting confounders, there were no significant differences of 30-day MACCE between 2 groups (2.0% versus 1.6%, adjusted hazard ratio: 0.7, 95% confidence interval: 0.1 to 8.6, *p*=0.772).

4. Discussion {#sec4}
=============

We reported on the first study aimed to evaluate the efficacy and safety of an optimized radiation strategy versus normal radiation strategy in P-PCI for STEMI patients. The results showed a good combination of significant radiation dose reduction and similar 30-day outcomes from the optimized radiation strategy.

Reducing radiation exposure for both patients and interventional staff is a universal aim. Previous study reported some radiation reduction measures \[[@B6]--[@B9], [@B13]\]. which were all carried out in routine coronary angiography or selective PCI. There exist some differences between P-PCI and selective PCI. In view of the critical clinical situation of STEMI patients, evaluation of blood flow, culprit lesions, and thrombus burden should be clearly and rapidly accomplished. With regard to procedure details, P-PCI perform more thrombus aspiration and intracoronary injection. Moreover, high incidence of no reflow in P-PCI also demands the accurate judgment of the flow status. All these situations raise a claim for a good image quality. However, the evaluation of radiation protocol optimization for P-PCI has never been reported.

In the present study, significant radiation dose reduction was achieved in ORS group. This effect comes at no difference in fluoroscopy time, or contrast volume between 2 groups. As an indicator for radiation efficiency, the EI value in ORS group was obviously superior to NRS group. Thus, optimized radiation strategy demonstrated an obvious advantage of effectiveness.

For experienced operators, rather than trainees who may take longer fluoroscopy time to position catheters, cine-angiography usually occupied a bigger proportion of radiation dose. Consequently, it would be easier to achieve obvious radiation dose reduction by decreasing cine-angiography frame rate. Other than reduced frame rate, adoption of an additional Al filter, which has been reported to have additional radiation reduction effect \[[@B14]\], may play a very important role in dose reduction. Of course, in view of different installation years of serial X-ray systems, the radiation exposure secondary to the age of the hardware should also be taken into consideration.

In terms of radiation exposure control, how to strike a good balance between radiation dose reduction and image quality is always the key obstacle to overcome. Importantly, image quality should not only be evaluated by subjective visual feedback but also by objective clinical indicators. In the present study, the 30-day MACCE in 2 groups were both low and similar. Of course, longer follow-up time would be more powerful to evaluate the clinical outcomes.

This study had several limitations. First, this study was a retrospective, single institution design and included relatively small number of patients. However, it was the first study in this field. Second, during the period of this study, more P-PCI was carried out following the optimized radiation strategy. We should acknowledge the selection bias due to the nature of study design was present.

5. Conclusions {#sec5}
==============

By investigating the efficacy and safety of an optimized radiation strategy in P-PCI for STEMI patients, we provided the primary evidence and experience in this field. The results of our study suggest that there would be considerable degree of radiation dose reduction in P-PCI for STEMI patients by applying proper optimized radiation strategy. It appears to be feasible and safe to carry out the optimized radiation strategy in P-PCI for STEMI patients.

This work was supported by the National Nature Science Foundation of China (81800227) and Shanghai Sailing Program (No. 16YF1401600).

Data Availability
=================

The raw data that support the findings of this study are available only with a reasonable request to the corresponding author.

Conflicts of Interest
=====================

The authors declare that they have no conflicts of interest.

Authors\' Contributions
=======================

Xin Zhong and Wei Gao contributed equally to this work.

![Flow chart of the study. P-PCI, primary percutaneous coronary intervention; STEMI, ST-segment--elevation myocardial infarction; ORS, optimized radiation strategy; NRS, normal radiation strategy.](CRP2019-6094806.001){#fig1}

![Radiation dose comparison among X-ray systems within groups. ORS, optimized radiation strategy; NRS, normal radiation strategy.](CRP2019-6094806.002){#fig2}

###### 

Baseline clinical characteristics.

                                                ORS group (*n* = 151)   NRS group (*n* = 63)   *p* value
  --------------------------------------------- ----------------------- ---------------------- -----------
  Gender, male                                  126 (83.4%)             55 (87.3%)             0.476
  Age (years)                                   64.4 ± 12.2             65.2 ± 11.4            0.683
  BMI (kg/m^2^)                                 24.0 ± 2.6              24.0 ± 3.2             0.906
  Medical history                                                                              
   Hypertension                                 99 (65.6%)              39 (61.9%)             0.610
   Diabetes                                     44 (29.1%)              15 (23.8%)             0.427
   Insulin-treated                              5 (3.3%)                3 (4.8%)               0.696
   Dyslipidemia                                 76 (50.3%)              26 (41.3%)             0.226
   Smoking                                      90 (59.6%)              36 (57.1%)             0.739
   Previous coronary intervention               43 (28.5%)              22 (34.9%)             0.350
   Previous CABG                                1 (0.7%)                1 (1.6%)               0.503
  Clinical presentation                                                                        
   Heart rate (beats/min)                       77.8 ± 15.4             75.9 ± 13.9            0.399
   Blood pressure (mm·Hg)                                                                      
   Systolic blood pressure                      120.7 ± 22.1            118.4 ± 20.4           0.489
   Diastolic blood pressure                     74.6 ± 14.2             71.7 ± 13.6            0.176
   Cardiogenic shock on presentation            4 (2.6%)                0 (0%)                 0.323
   Infarct location                                                                            
   Anterior                                     78 (51.7%)              27 (42.9%)             0.241
   Not anterior                                 73 (48.3%)              36 (57.1%)             
   Killip class                                                                                
   I                                            139 (92.1%)             57 (90.5%)             0.705
   II‒IV                                        12 (7.9%)               6 (9.5%)               
  Left ventricular ejection fraction^*∗*^ (%)   52.4 ± 7.5              52.8 ± 8.9             0.747

Continuous data are presented as mean ± SD; categorical data are expressed as counts (percentage). ORS: optimized radiation strategy; NRS: normal radiation strategy; BMI: body mass index; CABG: coronary artery bypass grafting. ^*∗*^Value for 210 patients.

###### 

Procedural and radiation dose characteristics.

                            ORS group (*n* = 151)   NRS group (*n* = 63)   *p* value
  ------------------------- ----------------------- ---------------------- -----------
  Radial artery access      147 (97.4%)             59 (93.7%)             0.238
  Multiple-vessel disease   109 (72.2%)             42 (66.7%)             0.419
  Infarct related artery                                                   
   LM                       1 (0.7%)                0 (0%)                 0.628
   LAD                      77 (51.0%)              27 (42.9%)             
   LCX                      15 (9.9%)               8 (12.7%)              
   RCA                      58 (38.4%)              28 (44.4%)             
  TIMI flow pre-PCI                                                        
   0                        96 (63.6%)              45 (71.4%)             0.252
   1                        20 (13.2%)              3 (4.8%)               
   2                        12 (7.9%)               7 (11.1%)              
   3                        23 (15.2%)              8 (12.7%)              
  Thrombus aspiration       108 (71.5%)             50 (79.4%)             0.234
  Non-culprit vessel PCI    8 (5.3%)                2 (3.2%)               0.727
  Stent number              1.5 ± 0.7               1.3 ± 0.8              0.241
  GPI use                                                                  
   During intervention      80 (53.0%)              31 (49.2%)             0.615
   After intervention       40 (26.5%)              21 (33.3%)             0.312
  Contrast volume (mL)      127.9 ± 43.8            122.4 ± 41.7           0.394
  Successful PCI            151 (100%)              62 (98.4%)             0.294
  Air kerma (mGy)           901.2 ± 628.7           1524.0 ± 866.6         \<0.001
  DAP (Gycm^2)^             57.1 ± 40.7             101.1 ± 59.4           \<0.001
  Fluoroscopy time (min)    20.1 ± 12.8             21.7 ± 17.4            0.439
  EI (min/Gy)               24.8 ± 9.5              16.0 ± 10.2            \<0.001

Continuous data are presented as mean ± SD; categorical data are expressed as counts (percentage). ORS: optimized radiation strategy; NRS: normal radiation strategy; LM: left main; LAD: left anterior descending artery; LCX: left circumflex artery; RCA: right coronary artery; TIMI: thrombolysis in myocardial infarction; PCI: percutaneous coronary intervention; GPI : GP IIb/IIIa inhibitor; DAP: dose-area product; EI: efficiency index.

###### 

Clinical Outcomes at 30 days.

                                                    ORS group (*n* = 151)   NRS group (*n* = 63)   Unadjusted HR (95% CI)   *p* value   Adjusted HR^*∗*^ (95% CI)   *p* value
  ------------------------------------------------- ----------------------- ---------------------- ------------------------ ----------- --------------------------- -----------
  MACCEs                                            3 (2.0%)                1 (1.6%)               1.3 (0.1--12.1)          0.844       0.7 (0.1--8.6)              0.772
  All cause death                                   3 (2.0%)                1 (1.6%)               1.3 (0.1--12.1)          0.844       0.7 (0.1--8.7)              0.774
  Reinfarction                                      0 (0%)                  0 (0%)                                          NA                                       
  Ischemia-driven target vessel revascularization   0 (0%)                  0 (0%)                                          NA                                       
  Stroke                                            1 (0.7%)                0 (0%)                                          1.000                                    

Categorical data are expressed as counts (percentage). ORS: optimized radiation strategy; NRS: normal radiation strategy; HR: hazard ratio; CI: confidence interval; MACCE: major adverse cardiac and cerebrovascular events; NA, not applicable. ^*∗*^Adjusted covariates included male, age, body mass index, diabetes, smoking, anterior infarction, multiple-vessel disease.
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